RDY
Dr. Reddy’s Laboratories Ltd
12.50$
+2.1%
vs. previous close
Closing price · As of: Sep 28, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +4.4% | -9.0% | +0.9% | +8.3% | +13.5% | -98.5% | +8,288.8% | +14.7% | +13.5% | +16.6% | +8.6% | |
| – | -0.6% | +0.0% | +5.2% | +7.1% | +14.4% | -98.4% | +7,893.6% | +6.0% | +8.5% | +16.9% | +23.6% | |
| – | +8.1% | -15.1% | -2.6% | +9.3% | +12.7% | -98.6% | +8,671.8% | +22.4% | +17.4% | +16.4% | -2.1% | |
| – | +2.2% | +9.6% | -6.6% | -14.6% | -1.3% | -98.6% | +8,290.1% | +10.9% | +18.0% | +19.7% | -7.5% | |
| – | +1.0% | +3.6% | +0.7% | -1.8% | +6,990.4% | +8.8% | +13.8% | -25.2% | +66.1% | +21.6% | -36.2% | |
| – | +6.0% | +3.5% | -0.7% | -2.9% | +24.7% | -98.9% | +9,637.8% | -2.6% | +16.6% | +23.7% | +16.1% | |
| – | +12.7% | -54.4% | -11.7% | +75.3% | -23.4% | -97.3% | +6,732.0% | +93.9% | +18.5% | +6.1% | -32.0% | |
| – | -24.4% | -23.2% | +24.3% | +12.8% | -98.4% | +6,896.8% | -1.2% | +49.1% | +19.8% | +65.3% | +39.0% | |
| – | -3.6% | -46.0% | -2.1% | +56.5% | -19.7% | -98.0% | +8,977.5% | +86.9% | +19.1% | +6.8% | -24.9% | |
| – | +19.1% | -63.3% | +73.5% | -19.6% | -140.2% | – | +6,963.5% | +75.3% | +5.8% | +20.7% | -33.5% | |
| – | -9.8% | -39.8% | -18.5% | +91.7% | +3.7% | -98.8% | +10,049.5% | +91.2% | +23.6% | +1.5% | -20.3% | |
| – | +15.9% | -37.9% | -4.6% | +50.3% | +17.6% | -98.7% | +8,329.7% | +65.1% | +18.8% | +9.3% | -13.8% |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.